
Sign up to save your podcasts
Or


In this episode of Resin Market Moves, Michael Workman, Executive Director of ResinSmart, walks through the key risks shaping the North American plastic resin market in early 2026.
Rather than a demand-led recovery, markets are being driven by:
Michael also shares insights from MD&M West 2026, where medical device manufacturers emphasized the high cost of pricing surprises in regulated, long-cycle environments — and why benchmarking is becoming the preferred first step.
This episode focuses on risk, structure, and discipline, not price predictions — and offers a framework buyers can use to navigate 2026 with confidence.
By ResinSmartIn this episode of Resin Market Moves, Michael Workman, Executive Director of ResinSmart, walks through the key risks shaping the North American plastic resin market in early 2026.
Rather than a demand-led recovery, markets are being driven by:
Michael also shares insights from MD&M West 2026, where medical device manufacturers emphasized the high cost of pricing surprises in regulated, long-cycle environments — and why benchmarking is becoming the preferred first step.
This episode focuses on risk, structure, and discipline, not price predictions — and offers a framework buyers can use to navigate 2026 with confidence.